Teratocarcinomas induced by embryonic stem (ES) cells lacking vimentin: An approach to study the role of vimentin in tumorigenesis

Journal of Cell Science

Volumn 113, Issue 19, 2000, Pages 3463-3472

  Langa, F ^a   Kress, C ^a   Colucci Guyon, E ^a   Khun, H ^a   Vandormael Pournin, S ^a   Huerre, M ^a   Babinet, C ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Embryonic stem cell; Knock out mice; Teratocarcinoma; Vimentin

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; EMBRYO DEVELOPMENT; FEMALE; GENE MUTATION; GENETIC CONSERVATION; GROWTH RATE; INTERMEDIATE FILAMENT; ISOGRAFT; KNOCKOUT MOUSE; MALE; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STEM CELL; TERATOCARCINOMA; TUMOR VASCULARIZATION; VERTEBRATE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; FEMALE; GERM-LINE MUTATION; IN SITU NICK-END LABELING; INTERMEDIATE FILAMENT PROTEINS; KARYOTYPING; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; NERVE TISSUE PROTEINS; STEM CELLS; TERATOCARCINOMA; VIMENTIN;

ANIMALIA; VERTEBRATA;

EID: 0033756724     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Derivation of embryonic stem cell lines
2. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms
3. Production and analysis of chimaeric mice
4. Expression of intermediate filament proteins in normal and diseased thyroid glands
5. Unexpected behavior of a gene trap vector comprising a fusion between the Sh ble and the lacZ genes
6. Involvement of vimentin in the reverse transformation reaction
7. Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility
8. Initial expression of neurofilaments and vimentin in the central and peripheral nervous system of the mouse embryo in vivo
9. Mice lacking vimentin develop and reproduce without an obvious phenotype
10. Cerebellar defect and impaired motor coordination in mice lacking vimentin
11. Embryo-derived teratocarcinoma elicit splenomegaly in syngeneic hosts
12. Teratocarcinoma: Neoplastic lessons about normal embryogenesis
13. Vimentin is preferentially expressed in human breast carcinoma with low oestrogen receptor and high Ki-67 growth fraction
14. p53 protein and vimentin in invasive ductal NOS breast carcinoma-relationship with survival and sites of metastases
15. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
16. Immunohistochemical demonstration of an organized cytoarchitecture of the radial glia in the CNS of the embryonic mouse
17. Impaired mechanical stability, migration, and contractile capacity in vimentin-deficient fibroblasts
18. Suppression of the chemically transformed phenotype of BHK cells by a human cDNA
19. Formation of cytoskeletal elements during mouse embryogenesis. III. Primary mesenchymal cells and the first appearance of vimentin filaments
20. Intermediate filaments: Structure, dynamics, function, disease
21. Myogenesis in the mouse embryo: Differential onset of expression of myogenic proteins and the involvement of titin in myofibril assembly
22. Differentiation and organization in teratomas
23. Disrupted glial fibrillary acidic protein network in astrocytes from vimentin knockout mice
24. Reflections on the biology of embryonic stem (ES) cells
25. The epithelial to mesenchymal transition and metastatic progression in carcinoma
26. The role of fibroblasts in tumor behavior
27. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
28. Genetic background alters the spectrum of tumors that develop in p53-deficient mice
29. Vimentin in benign and malignant lesions in the human mammary gland
30. Role of intermediate filaments in migration, invasion and metastasis
31. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior
32. Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin
33. Embryonic stem (ES) cells lacking functional c-jun: Consequences for growth and differentiation, AP-1 activity and tumorigenicity
34. Vimentin expression in 98 breast cancers with medullary features and its prognostic significance
35. Embryonic carcinoma and embryonal stem cells
36. Temporal relationship between the appearance of vimentin and neural tube development
37. Intermediate filament proteins. Diagnostic markers in tumour pathology
38. Nonpermissiveness for mouse embryonic stem (ES) cell derivation circumvented by a single backcross to 129/Sv strain: Establishment of ES cell lines bearing the Om(d) conditional lethal mutation
39. Co-expression of vimentin and cytokeratin in parietal endoderm cells of early mouse embryo
40. Vimentin: An evaluation of its role as a tumour marker
41. CNS stem cells express a new class of intermediate filament protein
42. Teratocarcinomas and mammalian embryogenesis
43. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells
44. Co-expression of intermediate filaments in human epithelial neoplasms
45. Germ cell development in the XXY mouse: Evidence that X chromosome reactivation is independent of sexual differentiation
46. Derivation of completely cell culture-derived mice from early passage embryonic stem cells
47. Teratocarcinoma-derived cell lines and their use in the study of differentiation
48. Intermediate filaments: Cell-type-specific markers in differentiation and pathology
49. Biology of disease: Tumor diagnosis by intermediate filament typing-A new tool for surgical pathology
50. Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells
51. Vimentin-a new prognostic parameter in breast carcinoma?
52. Embryo-derived stem cell lines
53. Altered flow-induced arterial remodeling in vimentin-deficient mice
54. The development of transplantable teratocarcinomas from intratesticular grafts of pre-and post-implantation mouse embryos
55. A new inbred strain in mice (129/ter Sv) with a high incidence of spontaneous congenital testicular teratomas
56. Reduction of renal mass is lethal in mice lacking vimentin
57. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
58. A method for preparing chromosomes from peripheral blood in the mouse
59. Coexpression of cytokeratins and vimentin in common epithelial tumours of the ovary: An immunocytochemical study of eighty-three cases